Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Zinc: A complementary factor in the treatment of chronic hepatitis C? (Review).

Grüngreiff K, Reinhold D.

Mol Med Rep. 2010 May-Jun;3(3):371-5. doi: 10.3892/mmr_00000267.

PMID:
21472249
2.

Treatment of chronic hepatitis C in Asia: when East meets West.

Yu ML, Chuang WL.

J Gastroenterol Hepatol. 2009 Mar;24(3):336-45. doi: 10.1111/j.1440-1746.2009.05789.x. Review.

PMID:
19335784
3.

Chronic hepatitis C virus infection in renal transplant: treatment and outcome.

Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, Prasad N.

Clin Transplant. 2006 Nov-Dec;20(6):677-83.

PMID:
17100715
4.

Ribavirin in the treatment of hepatitis C.

Abonyi ME, Lakatos PL.

Anticancer Res. 2005 Mar-Apr;25(2B):1315-20.

5.

Management issues in chronic viral hepatitis: hepatitis C.

Sievert W.

J Gastroenterol Hepatol. 2002 Apr;17(4):415-22. Review.

PMID:
11982722
6.

Hepatitis C virus and liver transplantation.

Ahmed A, Keeffe EB.

Clin Liver Dis. 2001 Nov;5(4):1073-90. Review.

PMID:
11685796
7.

[Immunology of hepatitis C: clinical significance of T cell response].

Shin EC.

Korean J Hepatol. 2006 Jun;12(2):140-53. Review. Korean.

PMID:
16804339
8.
9.

Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.

Seeff LB, Hoofnagle JH.

Clin Liver Dis. 2003 Feb;7(1):261-87. Review.

PMID:
12691470
10.

Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.

Chuang WL, Dai CY, Chang WY, Lee LP, Lin ZY, Chen SC, Hsieh MY, Wang LY, Yu ML.

Antivir Ther. 2005;10(1):125-33.

PMID:
15751770
11.

High dose daily interferon-alpha induction and secondary adjunction of ribavirin in treatment-naive patients with chronic hepatitis C. A multicentric, randomised, controlled trial.

Wartelle-Bladou C, Arpurt JP, Renou C, Pariente A, Pillon D, Nalet B, Picon M, Glibert A, Chousterman M, Grasset D, Morin T, Bernard P, Fischer D, Ramdani M, Lagier E, Rotily M; Viral Hepatitis Group of the ANGH.

Gastroenterol Clin Biol. 2006 Apr;30(4):525-32.

12.
13.

[Immunopathology of chronic liver diseases].

Meyer zum Büschenfelde KH.

Verh Dtsch Ges Pathol. 1995;79:186-97. Review. German.

PMID:
8600684
14.

Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.

Czerwionka-Szaflarska M, Chrobot A, Szaflarska-Szczepanik A.

Med Sci Monit. 2000 Sep-Oct;6(5):964-70.

PMID:
11208439
15.

Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.

Abdelmalek MF, Firpi RJ, Soldevila-Pico C, Reed AI, Hemming AW, Liu C, Crawford JM, Davis GL, Nelson DR.

Liver Transpl. 2004 Feb;10(2):199-207.

16.

Long-term treatment of chronic hepatitis C with ursodeoxycholic acid: influence of HCV genotypes and severity of liver disease.

Lirussi F, Beccarello A, Bortolato L, Morselli-Labate AM, Crovatto M, Ceselli S, Santini G, Crepaldi G.

Liver. 1999 Oct;19(5):381-8.

PMID:
10533795
17.

Treatment of hepatitis C virus infection in patients with end-stage renal disease.

Liu CH, Kao JH.

J Gastroenterol Hepatol. 2011 Feb;26(2):228-39. doi: 10.1111/j.1440-1746.2010.06488.x. Review.

PMID:
21261711
18.

Evaluation of interleukin-8 in hepatitis C virus infection: relation to combined peg-interferon ribavirin response and genotype 4.

El Sayed ZM, Mansour FA, Ghal MF, Abou-Zahra SB.

Immunol Invest. 2011;40(1):29-38. doi: 10.3109/08820139.2010.508192. Epub 2010 Sep 1.

PMID:
20809700
19.

Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.

Zografos TA, Liaskos C, Rigopoulou EI, Togousidis E, Makaritsis K, Germenis A, Dalekos GN.

Am J Gastroenterol. 2008 Mar;103(3):605-14. doi: 10.1111/j.1572-0241.2007.01729.x. Epub 2008 Jan 8.

PMID:
18190648
20.

Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.

Soriano V, Núñez M, Camino N, Maida I, Barreiro P, Romero M, Martin-Carbonero L, Garcia-Samaniego J, González-Lahoz J.

Antivir Ther. 2004 Aug;9(4):505-9.

PMID:
15456081

Supplemental Content

Support Center